Literature DB >> 12854164

Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats.

Jin-Lian Chen1, Tong Zhou, Wei-Xiong Chen, Jin-Shui Zhu, Ni-Wei Chen, Ming-Jun Zhang, Yun-Lin Wu.   

Abstract

AIM: To investigate the effect of tetramethylpyrazine on hepatic/renal ischemia and reperfusion injury in rats.
METHODS: Hepatic/renal function, histopathological changes, and hepatic/renal P-selectin expression were studied with biochemical measurement and immunohistochemistry in hepatic/renal ischemia and reperfusion injury in rat models.
RESULTS: Hepatic/renal insufficiency and histopathological damage were much less in the tetramethylpyrazine-treated group than those in the saline-treated groups. Hepatic/renal P-selectin expression was down regulated in the tetramethylpyrazine-treated group.
CONCLUSION: P-selectin might mediate neutrophil infiltration and contribute to hepatic/renal ischemia and reperfusion injury. Tetramethylpyrazine might prevent hepatic/renal damage induced by ischemia and reperfusion injury through inhibition of P-selectin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854164      PMCID: PMC4615505          DOI: 10.3748/wjg.v9.i7.1563

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

1.  Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.

Authors:  W Chen; C F Bennett; T P Condon; K Stecker; L Tian; B D Kahan; S M Stepkowski
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives.

Authors:  Y Yabe; N Kobayashi; T Nishihashi; R Takahashi; M Nishikawa; Y Takakura; M Hashida
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

3.  Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation.

Authors:  Paul Kubes; Derrice Payne; Richard C Woodman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

4.  Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat.

Authors:  K Bojakowski; P Abramczyk; M Bojakowska; A Zwolińska; J Przybylski; Z Gaciong
Journal:  J Physiol Pharmacol       Date:  2001-03       Impact factor: 3.011

5.  Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury.

Authors:  J Deng; Y Kohda; H Chiao; Y Wang; X Hu; S M Hewitt; T Miyaji; P McLeroy; B Nibhanupudy; S Li; R A Star
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation.

Authors:  M A Weigand; J Plachky; J C Thies; D Spies-Martin; G Otto; E Martin; H J Bardenheuer
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

7.  Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats.

Authors:  T Zhou; X Li; P Wu; D Zhang; M Zhang; N Chen; D Dong
Journal:  Chin Med J (Engl)       Date:  2000-09       Impact factor: 2.628

8.  Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver.

Authors:  N Kojima; M Sato; A Suzuki; T Sato; S Satoh; T Kato; H Senoo
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

9.  Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates.

Authors:  M Li; S Handa; Y Ikeda; S Goto
Journal:  Thromb Res       Date:  2001-10-01       Impact factor: 3.944

10.  Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury.

Authors:  Jean Pierre Faure; Thierry Hauet; Zeqiu Han; Jean Michel Goujon; Isabelle Petit; Gerard Mauco; Michel Eugene; Michel Carretier; Vassilios Papadopoulos
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  6 in total

1.  Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury.

Authors:  Jing Ying; Jin Wu; Yiwei Zhang; Yangyang Han; Xinger Qian; Qiuhong Yang; Yongjie Chen; Yijun Chen; Hao Zhu
Journal:  Mol Cell Biochem       Date:  2019-11-16       Impact factor: 3.396

2.  Beneficial Effects of Insulin on Ischemia Reperfusion Injury in Human Skeletal Muscle.

Authors:  Thushan Dhananja Gooneratne; Shervanthi Homer-Vanniasinkam; Serosha Mandika Wijeyaratne
Journal:  Vasc Specialist Int       Date:  2022-09-30

Review 3.  Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis.

Authors:  Jun Li; Xuezhong Gong
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

4.  A systematic review and meta-analysis of treatment for hepatorenal syndrome with traditional Chinese medicine.

Authors:  Tingxue Song; Xiaozhong Guo; Lichun Shao; Mingyu Sun; Fernando Gomes Romeiro; Dan Han; Wenchun Bao; Xingshun Qi
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-22

Review 5.  Mechanisms and Clinical Application of Tetramethylpyrazine (an Interesting Natural Compound Isolated from Ligusticum Wallichii): Current Status and Perspective.

Authors:  Yingke Zhao; Yue Liu; Keji Chen
Journal:  Oxid Med Cell Longev       Date:  2016-09-07       Impact factor: 6.543

Review 6.  Application of Herbal Traditional Chinese Medicine in the Treatment of Acute Kidney Injury.

Authors:  Hai-Di Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.